v3.26.1
Recent Transactions and Developments (Tables)
12 Months Ended
Mar. 31, 2026
Recent Transactions and Developments [Abstract]  
Schedule of Calculation of Gain The following table summarizes the calculation of the gain recognized during the year ended March 31, 2024 (in thousands).
Consideration:
Upfront cash payment$5,234,373 
Carrying amount of noncontrolling interest derecognized87,500 
Total consideration5,321,873 
Assets sold3,253 
Liabilities transferred29,790 
Net liabilities sold(26,537)
Gain on sale of Telavant net assets$5,348,410